Abiomed

E849997

Abiomed is a medical device company best known for its heart support and circulatory assist technologies, including the Impella family of heart pumps.

Try in SPARQL Jump to: Statements Referenced by

Statements (49)

Predicate Object
instanceOf medical device company
public company
acquiredBy Johnson & Johnson NERFINISHED
acquisitionAnnounced 2022
acquisitionCompleted 2022
aimsTo improve survival in cardiogenic shock
provide hemodynamic support
collaboratesWith cardiologists
cardiothoracic surgeons
hospitals
countryOfOrigin United States of America
surface form: United States
develops Impella heart pump NERFINISHED
percutaneous ventricular assist devices
focusesOn circulatory assist technologies
heart support technologies
formerName Applied Biomedical Corporation NERFINISHED
foundedBy David M. Lederman NERFINISHED
hasOffice Aachen, Germany NERFINISHED
Tokyo, Japan NERFINISHED
hasSubsidiaryOrBrand Abiomed Europe NERFINISHED
hasTechnology minimally invasive heart pumps
percutaneous catheter-based pumps
headquartersLocation Danvers, Massachusetts, United States NERFINISHED
inception 1981
industry cardiovascular devices
medical devices
knownFor Impella family of heart pumps NERFINISHED
listedOn NASDAQ
parentOrganization Johnson & Johnson NERFINISHED
Johnson & Johnson MedTech NERFINISHED
products Impella 2.5 NERFINISHED
Impella 5.0 NERFINISHED
Impella 5.5 NERFINISHED
Impella BTR NERFINISHED
Impella CP NERFINISHED
Impella ECP NERFINISHED
Impella LD NERFINISHED
Impella RP NERFINISHED
regulatoryStatus CE-marked devices
FDA-approved devices
researchFocus heart recovery
high-risk percutaneous coronary intervention support
serves cardiac surgery market
cardiology market
critical care market
specializesIn acute cardiac support
mechanical circulatory support
tickerSymbol ABMD NERFINISHED
website https://www.abiomed.com

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.